We help eligible patients access Xifaxan (rifaximin) for IBS-D treatment and hepatic
encephalopathy prevention for as little as $69.95 per month through manufacturer Patient
Assistance Programs.
The Xifaxan Prescription Assistance Program is a manufacturer-sponsored initiative that provides Xifaxan at no medication cost to qualifying patients. For commercially insured patients, a copay savings card reduces costs to as little as $0 per prescription.
AffordMyPrescriptions ensures effective gut treatment is accessible. For a flat $69.95 per month, our Patient Advocates manage your enrollment for any indication — traveler’s diarrhea, IBS-D, or hepatic encephalopathy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$2,400 | Save ~$2,330/mo |
| CVS Pharmacy | ~$2,352 | Save ~$2,282/mo |
| Walmart | ~$2,360 | Save ~$2,290/mo |
| Costco | ~$2,350 | Save ~$2,280/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management. Our $69.95/month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution:
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements can vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation.
Xifaxan (rifaximin) is a prescription gut-specific antibiotic. For traveler’s diarrhea: 200 mg three times daily for 3 days. For IBS-D: 550 mg three times daily for 14 days (repeatable up to two additional courses). For hepatic encephalopathy prevention: 550 mg twice daily on an ongoing basis. Less than 1% is absorbed systemically.
How It Works:
For traveler’s diarrhea, it kills E. coli directly in the intestines. For IBS-D, it reduces small intestinal bacterial overgrowth (SIBO). For hepatic encephalopathy, it targets ammonia-producing bacteria in the gut, preventing the toxic buildup that causes confusion and cognitive decline.
Form and Use:
Available in 200 mg and 550 mg tablets. Dosing varies by indication. For HE, treatment is ongoing and indefinite.
Generic/Biosimilar Availability:
As of April 2026, no generic rifaximin is available. Based on patent settlements, generic entry is not expected until approximately 2029.
Warnings:
For hepatic encephalopathy patients: do NOT stop Xifaxan without consulting your hepatologist. Feeling better is a sign the medication is working, not that you no longer need it.
Xifaxan 550 mg costs approximately $2,352–$3,594 for 60 tablets. Hepatic encephalopathy treatment costs $1,600–$2,400/month ongoing. Through AffordMyPrescriptions, qualifying patients receive Xifaxan at no cost for $69.95/month.
Traveler’s diarrhea: 3 days. IBS-D: 14 days (repeatable up to 2 additional times). Hepatic encephalopathy: ongoing indefinitely.
Its unique gut-specific mechanism, specialized indications, and lack of generic competition (patentprotection until ~2029) all contribute to its high price.
No. HE prevention requires continuous treatment. Stopping allows ammonia-producing bacteria to regrow and HE episodes to recur.
No. Generic rifaximin is not expected until approximately 2029.
If you are struggling with the high cost of Xifaxan, our team may be able to help you access
assistance programs designed to make medications more affordable. Check your eligibility
today and take the first step toward reducing your prescription costs.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.